MCL1 and cancer: Some reports have suggested that MCL1 suppression by MCL1 siRNA and antisense oligonucleotides enhance the antitumor effects of chemotherapy in human cancers including sarcomas7, hepatocellular carcinomas32, pancreatic cancers33 and gastric cancers34.